Diagnosis, complication and treatment of acute salbutamol toxicity
Keywords:Salbutamol, Asthma, Treatment, Toxicity
Salbutamol is a well-known example of a short-acting beta agonist that is used as therapy for managing asthma, bronchospasm and chronic obstructive pulmonary disease. Short-acting beta agonist without a controller should only be taken into consideration as needed if symptoms are minimal and there is no asthma-related awakening. Salbutamol's maximal efficacy is based on how it is administered and the formulation that is utilized. Inhaled salbutamol is a first-line treatment for the majority of patients because it provides quick bronchodilation and typically relieves bronchospasm within minutes. Salbutamol immediately relieves the symptoms of acute asthma by relaxing the smooth muscle in the airways and boosting airflow. Patient experiences immediate relief from coughing, wheezing, tightness in the chest, and shortness of breath. Salbutamol's fast alleviation of symptoms may encourage abuse and overuse, especially in adolescents. On the basis of clinical and laboratory results, the diagnosis of salbutamol toxicity can be formed. The management is primarily supportive and includes stopping the harmful agent and using beta blockers to relieve symptoms. The purpose of this research is to review the available information about diagnosis, complication and treatment of acute salbutamol toxicity. Salbutamol overdose may cause tremors, hyperglycemia, lactic acidosis, and cardiac arrhythmias. Treatment for patients with severe symptoms include administration of beta-blockers if there are no contraindications also potassium supplementation, activated charcoal and gastric lavage among commonly used therapeutic strategies. Although salbutamol toxicity is uncommon still the physicians shall be knowledgeable about the diagnosis and management of salbutamol toxicity due to its widespread usage.
Wagner L, Kenreigh C, Furman B. Albuterol. In: Reference Module in Biomedical Sciences. Elsevier. 2018.
Gulley SL, Baltzley SM, Junkins AD. Sterility and Stability Testing of Preservative-free Albuterol. The journal of pediatric pharmacology and therapeutics : JPPT: the official journal of PPAG. 2019;24(1):53-7.
Zheng B, Yadav K. Acute salbutamol toxicity in the emergency department: A case report. World J Emergency Med. 2021;12(1):73-5.
Morgan JC, Mehta SH, Sethi KD. Tremor: Drug-induced. In: Kompoliti K, Metman LV, eds. Encyclopedia of Movement Disorders. Oxford: Academic Press. 2010;285-9.
Gad SE. Albuterol. In: Wexler P. Encyclopedia of Toxicology (Second Edition). New York: Elsevier; 2005:61-62.
Syed SA, Sherwani NZF, Riaz B. Short-Term Effect of Inhaled Salbutamol on Heart Rate in Healthy Volunteers. Cureus. 2021;13(3):e13672.
Elgassim M, Abdelrahman A, Saied ASS. Salbutamol-Induced QT Interval Prolongation in a Two-Year-Old Patient. Cureus. 2022;14(2):e21904.
Tobin A. Intravenous salbutamol: too much of a good thing? Crit Care Resuscitation. 2005;7(2):119-27.
Tomar RP, Vasudevan R. Metabolic acidosis due to inhaled salbutamol toxicity: A hazardous side effect complicating management of suspected cases of acute severe asthma. Med J Armed Forces Ind. 2012;68(3):242-4.
Lewis LD, Essex E, Volans GN, Cochrane GM. A study of self poisoning with oral salbutamol--laboratory and clinical features. Human Exp Toxicol. 1993;12(5):397-401.
Yilmaz HL, Kucukosmanoglu O, Hennes H, Celik T. Salbutamol intoxication: is salbutamol a drug-inducing fever? A case report and treatment strategy. European journal of emergency medicine : official journal of the European Society for Emergency Med. 2002;9(2):179-82.
Danenberg HD. [Salbutamol intoxication]. Harefuah. 1997;132(8):549-51.
Minton NA, Baird AR, Henry JA. Modulation of the effects of salbutamol by propranolol and atenolol. Eur J Clin Pharmacol. 1989;36(5):449-53.
Habib GS, Saliba WR, Cohen L. Diabetic ketoacidosis associated with oral salbutamol overdose. Am J Med. 2002;113(8):701-2.
Chandrasekaran VP, Parthasarathy A, Muruga B, Senthamil, Tharanesh. Theophylline toxicity: Successful management of a patient with distributive shock secondary to drug overdose. The American journal of emergency Med. 2020;38(11):2491.
Jones SL, Taylor DR. Excessive use of inhaled salbutamol: the potential benefits of dose-reduction. A case report. N Zeal Med J. 1999;112(1100):448-50.
Boucher A, Payen C, Garayt C. Salbutamol misuse or abuse with fatal outcome: a case-report. Human Exp Toxicol. 2011;30(11):1869-71.